Med Hexagon: Home

We support clients in
maximizing portfolio value
through a global network
spanning Asia, the U.S., and Europe

Headquarter

BD/Financing

Financing

Commercialization

Our services are tailored to the needs of parties in the innovative
pharmaceutical space seeking raise capital, partner, acquire, invest or divest

Fundraising

·Private equity financing
·Domestic and foreign financial/strategic investment

What we can do

Fundraising

·Valuation support
·Pitch deck preparation
·Roadshow support
·Sourcing and sounding
·Deal structure and term sheet review
·Due diligence support
·Negotiation support
Cross-region BD deals

· License-in/out
· New-Co
· M&A
· Ex-China commercialization

What we can do

Cross-region BD deals

·Process management, set work plan andtimeline
·Coordination with other external advisors (e.g.legal, finance, tax)
·Material preparation (including teasers,valuation, dataroom compilation, etc.)
·Due diligence coordination with internalstakeholders
·Sounding and screening for shortlist buyersor sellers
·Evaluation on deal structure, term sheets andlong forms, as well as negotiation support
·Post merger transition /integration support
Strategic Consulting

·Market assessment
·Pipeline evaluation
·BD strategy
·Market access and pricing strategy
·Company establishment

What we can do

Strategic Consulting

·Market assessment
·BD strategy planning
·Valuation
·Competitive intelligence

Our BD management team consists of seasoned individuals with
fundraising / licensing /management consulting experience from all sides of the table

Michael Li

· Michael has 15+ years of life science industry experience ranging from Financing, M&A, corporate business development to management consulting, geographically spanning across UK and China
· Most recently, he has conducted several out-bound partnership deals at LianBio, while previously advising over 40 deals as a Director at China Renaissance. Specializing in biotech fundraising, M&A and licensing deals
· Michael has a BSc from Peking University, an MPhil from Bath University, and an MBA from University of Cambridge
Tiffany Ko

·Tiffany has 10+ years of life science industry experience ranging from health economics, management consulting to corporate business development, geographically spanning across U.S. and China
·Most recently she has conducted several partnerships deals at LianBio, while previously consulting over 60+ projects at L.E.K. Consulting Shanghai and Boston offices. Specializing in search and evaluation, licensing transactions and corporate business strategy
·Tiffany has a MD/MSc from Shanghai Jiaotong University Medical School, and an MSc from University of York

· Michael has 15+ years of life science industry experience ranging from Financing, M&A, corporate business development to management consulting, geographically spanning across UK and China
· Most recently, he has conducted several out-bound partnership deals at LianBio, while previously advising over 40 deals as a Director at China Renaissance. Specializing in biotech fundraising, M&A and licensing deals
· Michael has a BSc from Peking University, an MPhil from Bath University, and an MBA from University of Cambridge

·Tiffany has 10+ years of life science industry experience ranging from health economics, management consulting to corporate business development, geographically spanning across U.S. and China

·Most recently she has conducted several partnerships deals at LianBio, while previously consulting over 60+ projects at L.E.K. Consulting Shanghai and Boston offices. Specializing in search and evaluation, licensing transactions and corporate business strategy

·Tiffany has a MD/MSc from Shanghai Jiaotong University Medical School, and an MSc from University of York

MedHexagon is differentiated by a life-science trained team with industry BD and fundraising track records and a flexible, customized approach to accommodate each project’s unique needs

Cross-border Access

Includes Greater China, Asia Pacific (excl. China), U.S., LATAM, Europe
Comprehensive China Coverage

Extensive reach among local innovative biotech, local commercial pharma, MNCs and investors
Years of Biotech Industry BD/ Financing Experience + Professional Service Track Record

Tailored Services

Flexible in meeting client needs regarding scope, timeline, topic, project needs, and communication style
Process-Driven Approach

Each step of pre-alignment workplan correctly executed to ensure systematic approach and optimal results
Scientifically- Trained Team

Core team consists of individuals trained in molecular medicine/ pharmacology and possessing deep scientific knowledge

We have access to an extensive network of investors/companies in Asia as well as in Europe and the U.S.

Biopharma Companies
Family Offices
VC/PE Funds
Large Financial Institutions
Corporate Ventures

We have an established BD network among multinational companies

Mega-Cap

(Mkt Cap > $200B)
Large-Cap

(Mkt Cap $10 - $200B)

80+ Companies

Mid-Cap(Mkt Cap $2 - $10B)

100+ Companies

Small-Cap(Mkt Cap $300M - $2B)

800+ Companies

Private Companies

Global Heads of
Business Development

Internal and
External KOLS

R&D Heads of
Therapeutic Areas

For those seeking to tap into the China local R&D ecosystem, our reach extends well beyond commercial stage pharma, deep into the frontiers of local innovation

· Our network encompasses hundreds of biotech companies in China and their investors

· We have direct access to an unparalleled network of executive management team members in the Chinese biotech industry,including:

CEOs

Head of Business Development

CFOs

R&D Head of Therapeutic Area

We support clients in
maximizing portfolio value
through a global network
spanning Asia, the U.S., and Europe

Our services are tailored to the needs of parties in the innovative
pharmaceutical space seeking raise capital, partner, acquire, invest or divest

Fundraising

What we can do

Fundraising

Cross-region BD deals

What we can do

Cross-region BD deals

Strategic Consulting

What we can do

Strategic Consulting

Our BD management team consists of seasoned individuals with
fundraising / licensing /management consulting experience from all sides of the table

Michael Li

Tiffany Ko

MedHexagon is differentiated by a life-science trained team with industry BD and fundraising track records and a flexible, customized approach to accommodate each project’s unique needs

Cross-border Access

Comprehensive China Coverage

Years of Biotech Industry BD/ Financing Experience + Professional Service Track Record

Tailored Services

Process-Driven Approach

Scientifically- Trained Team

We have access to an extensive network of investors/companies in Asia as well as in Europe and the U.S.